Result of AGM

Assura PLC

06 July 2023

 

6 July 2023

Assura plc ("Company")

Result of AGM

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 2 June 2023) were passed by the requisite majorities on a poll.

Resolution	For	% For	Against	% Against	Total Votes Cast (% of issued share capital)	Votes Withheld
1. To receive the Company's report and accounts	2,404,255,196	99.93	1,633,381	0.07	2,405,888,577(81.18)	1,591,592
2. To approve the Directors' Remuneration Report	2,341,833,957	97.77	53,533,946	2.23	2,395,367,903 (80.82)	12,112,266
3. To re-appoint Ernst & Young LLP as auditor of the Company	2,405,682,727	99.93	1,747,896	0.07	2,407,430,623 (81.23)	49,546
4. To authorise the Audit Committee to determine the auditor's remuneration	2,407,370,213	99.99	86,743	0.00	2,407,456,956 (81.23)	23,213
5. To re-elect Ed Smith as a Director of the Company	2,233,952,170	95.20	112,717,776	4.80	2,346,669,946 (79.18)	60,810,223
6. To re-elect Louise Fowler as a Director of the Company	2,383,530,756	99.01	23,915,485	0.99	2,407,446,241 (81.23)	33,928
7. To re-elect Jonathan Murphy as a Director of the Company	2,399,732,255	99.68	7,711,891	0.32	2,407,444,146 (81.23)	36,023
8. To re-elect Jayne Cottam as a Director of the Company	2,375,836,492	98.69	31,610,664	1.31	2,407,447,156 (81.23)	33,013
9. To re-elect Jonathan Davies as a Director of the Company	2,384,867,137	99.06	22,576,095	0.94	2,407,443,232 (81.23)	36,937
10. To re-elect Sam Barrell as a Director of the Company	2,384,892,936	99.06	22,550,296	0.94	2,407,443,232 (81.23)	36,937
11. To re-elect Emma Cariaga as a Director of the Company	2,406,157,355	99.95	1,285,877	0.05	2,407,443,232 (81.23)	36,937
12. To re-elect Noel Gordon as a Director of the Company	2,387,372,443	99.17	20,070,789	0.83	2,407,443,232 (81.23)	36,937
13. To authorise the Directors to allot shares	2,298,635,357	95.54	107,364,047	4.46	2,405,999,404 (81.18)	1,480,765
14. To empower the Directors to disapply pre-emption rights	2,377,573,799	98.82	28,407,039	1.18	2,405,980,838(81.18)	1,499,331
15. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment	2,295,995,741	95.62	105,215,996	4.38	2,401,211,737 (81.02)	6,268,432
16. To authorise the market purchase of the Company's own shares	2,405,270,604	99.99	290,670	0.01	2,405,561,274(81.17)	1,918,895
17. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice	2,277,947,643	94.62	129,482,515	5.38	2,407,430,158 (81.23)	50,011

Resolutions 1-13 were passed as ordinary resolutions. Resolutions 14-17 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 5 July 2023 was 2,963,648,116 of which the Total Voting Rights figure was 2,963,648,116.

Copies of resolutions 14-17, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, General Counsel David Purcell, Investor Relations Director	Email: [e-mail]
FGS Global Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

 

END